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Abstract Engineered skeletal muscle tissues are ideal
candidates for applications in drug screening systems,
bio-actuators, and as implantable constructs in tissue
engineering. Electrical field stimulation considerably
improves the differentiation of muscle cells to muscle
myofibers. Currently used electrical stimulators often
use direct contact of electrodes with tissue constructs or
their culture medium, which may cause hydrolysis of the
culture medium, joule heating of the medium, contami-
nation of the culture medium due to products of electro-
des corrosion, and surface fouling of electrodes. Here, we
used an interdigitated array of electrodes combined with
an isolator coverslip as a contactless platform to electri-
cally stimulate engineered muscle tissue, which elimi-
nates the aforementioned problems. The effective
stimulation of muscle myofibers using this device was
demonstrated in terms of contractile activity and higher
maturation as compared to muscle tissues without apply-
ing the electrical field. Due to the wide array of potential
applications of electrical stimulation to two- and three-
dimensional (2D and 3D) cell and tissue constructs, this
device could be of great interest for a variety of biolog-
ical applications as a tool to create noninvasive, safe, and
highly reproducible electric fields.
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1 Introduction
Skeletal muscle tissues have the ability to self-repair; how-
ever, they lack the potential to restore damage caused by
congenital defects, trauma, denervation, and tumor ablation.
In addition, intramuscular injection of myogenic cells, such
as satellite cells or myoblasts, does not effectively make
tissue repair due to low cell retention and survival, immu-
norejection, and functional loss (Rossi et al. 2010). Muscle
tissue engineering has recently been suggested as a promis-
ing method to regenerate or recover damaged muscle tissues
(Hinds et al. 2011; Koning et al. 2009). Engineered muscle
tissues also have in vitro applications, such as for drug
screening (Ghaemmaghami et al. 2012; Vandenburgh
2009) or as engineered bio-actuators (Hosseini et al. 2012;
Fujita et al. 2011).
It is well known that muscle cells are able to differentiate
under stimulation with an electrical field, which leads to an
increase in myosin production and the formation of myo-
fibers and contractile proteins (Park et al. 2008). Advances
in microscale technologies used in biology and regenerative
medicine (Khademhosseini et al. 2006) can provide reliable
methods and devices to enable the use of electrical stimula-
tion (ES) for tissue engineering applications in a precise and
controllable manner. In our previous work (Ahadian et al.
2012), an interdigitated array of electrodes was used for the
ES of muscle tissue, which had the following advantages:
(a) the electrodes were permanently positioned on the sub-
strate and could therefore provide a highly reproducible and
well-quantified electric field; (b) this technology made it
feasible to fabricate high resolution and complex electrode
designs relevant to physiological feature sizes and architec-
tures; (c) the ES was synchronized over the whole tissue; (d)
lower energy was needed to create a specified electric field
compared to the conventional setups for the ES (i.e., pair of
conductive electrodes placed in close proximity to the mus-
cle tissue). However, any direct contact between electrodes
and biological samples as occurred in our suggested device
may cause (1) hydrolysis of the culture medium when
applied electric potential exceeds the water window and
therefore it causes bubble formation; (2) joule heating of
the medium; (3) contamination of the culture medium due to
products of electrodes corrosion; (4) surface fouling of
electrodes as a result of electrochemical reactions on the
electrodes surface. To tackle these problems, we propose to
use a thin coverslip between the muscle tissue and interdig-
itated array of electrodes to make a contactless electrical
stimulator as depicted in Fig. 1.
In this study, we used gelatin methacrylate (GelMA) hydro-
gel, similar to our previous work (Aubin et al. 2010) to
fabricate 3D arrays of engineered muscle tissue. Hydrogels
have been employed extensively in biological applications
because they have a high water content and mimic many
features of the natural extracellular matrix (ECM) (Peppas et
al. 2006; Slaughter et al. 2009). GelMA hydrogel is an inex-
pensive, photopolymerizable semi-natural hydrogel com-
prised of gelatin modified with acrylates (Aubin et al. 2010).
In this work, we demonstrate the potential advantages of
a contactless interdigitated array of Pt (IDA-Pt) electrodes in
comparison to IDA-Pt electrodes stimulating muscle tissues
made on microgrooved GelMA hydrogel. The engineered
tissue was subjected to the ES as a means to accelerate the
tissue maturation. In this step, a contactless IDA-Pt electro-
des was introduced as a platform for the ES of muscle tissue,
and the resulting tissue was characterized and compared
with that without applying the electrical field. Due to the
wide array of potential applications of ES to two- and three-
dimensional (2D and 3D) cell and tissue constructs (Hronik-
Tupaj and Kaplan 2012), the proposed device could be of
great interest for a variety of biological applications as a tool
to create noninvasive, accurate, safe, and highly reproducible
direct and alternative electric fields.
2 Materials and methods
2.1 Materials
Positive g-line photoresist (i.e., S1818) and developer (i.e.,
MF CD-26) were purchased from Shipley Far East Ltd.,
Japan. Hexamethyldisilazane was purchased from Tokyo
Ohka Kogyo Co., Ltd., Japan. Methacrylic anhydride, 3-
(trimethoxysilyl)propyl methacrylate (TMSPMA), gelatin
Type A made of porcine skin, and penicillin/streptomycin
(P/S) were purchased from Sigma-Aldrich Chemical Co.,
USA. 2-Hydroxy-1-(4-(hydroxyethoxy) phenyl)-2-methyl-
1-propanone (i.e., Irgacure 2959) was purchased from Ciba
Chemicals, Japan. Polydimethylsiloxane (PDMS) was pur-
chased from Dow Corning Toray Co. Ltd., Japan. Trichloro
(1H, 1H, 2H, 2H-tridecafluro-n-octyl) silane was purchased
from Tokyo Chemical Industry Co., Japan. Fetal bovine
serum (FBS) was obtained from Bioserum, Japan. Dulbec-
co’s modified Eagle’s medium (DMEM), trypsin/EDTA,
MEM essential amino acid, MEM nonessential amino acid,
and insulin were obtained by Invitrogen, USA.
2.2 GelMA hydrogel synthesis and preparation
of its prepolymer
GelMA hydrogel was synthesized as described in our pre-
vious work (Aubin et al. 2010). In summary, a high degree
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of methacrylation (~80 %) was obtained by adding 8 mL
methacrylic anhydride to 10 g of gelatin in PBS for 3 h at
50 °C. The mixture was dialyzed with a 12–14 kDa cutoff
dialysis membrane against distilled water for one week at
40 °C and then lyophilized for 1 week. The GelMA hydro-
gel was kept at −20 °C until use.
GelMA hydrogel (20 % [w/v]) was combined with the
phosphate buffered saline (PBS) and 1 % (w/v) photoinitiator
(i.e., Irgacure 2959), kept at 60 °C until fully dissolved to obtain
the GelMA prepolymer, and then used for the experiments.
2.3 Cell culture
The C2C12 myoblast cell line was purchased from the
American Type Culture Collection (ATCC), USA. The cells
were cultured in the DMEM supplemented with 10 % FBS
and 1 % P/S, and used for the experiments at passage 7. The
C2C12 myoblasts were trypsinized using 0.25 % trypsin/
0.1 % EDTA when 70–80 % confluence was reached. The
cells were maintained in a cell culture incubator (Sanyo,
Japan) with a 5 % CO2 at 37 °C.
2.4 Microfabrication of GelMA templates for muscle tissue
engineering
To generate micromolds for fabricating microengineered
GelMA templates (groove-ridge micropatterns with
dimensions: groove 50 μm, ridge 50 μm, and height
50 μm), the PDMS stamp (see Supplementary information
for fabrication procedure of PDMS stamp) was initially
silanized by using trichloro(1H, 1H, 2H, 2 H-tridecafluro-n-
octyl) silane to prevent the adhesion of the GelMA polymer. A
coverslip (No. 000, thickness 50 μm; Matsunami Co., Japan)
mounted on the IDA-Pt electrodes (Ramón-Azcón et al. 2012)
(see Supplementary information for detailed information on
design and fabrication of electrodes) was acrylated with the
TMSPMA. Note that the coverslip was fixed on the IDA-Pt
electrodes using a plastic tape such that there was no direct
contact between the electrodes and their surrounding medium.
The GelMA hydrogel was then molded on the acrylated
coverslip on the IDA-Pt electrodes with the aid of the PDMS
stamp such that the GelMAmicropattern was perpendicular to
the direction of the electrode bands as illustrated in Fig. 1. To
fabricate the GelMA microstructures, 20 μL of GelMA
prepolymer was poured onto the device. Then, the PDMS
stamp was gently placed on the surface to completely fill
the microgrooves of the stamp with the GelMA hydrogel,
and the pattern was then exposed to 7 mW/cm2 UV light
(Hayashi UL-410UV-1, Hayashi Electronic Shenzen Co., Ltd.,
Japan) for 150 s. Afterwards, the PDMS stamp was gently
removed, leaving the GelMA micropattern on the IDA-Pt
electrodes.
For cell culture on the GelMA micropattern, the C2C12
myoblasts were trypsinized, counted, and resuspended in
(1) Fabrication of interdigitated 
array of Pt-electrodes covered with 
a thin glass coverslip
(2) Micromolding of GelMA 
hydrogel  
on the covered electrode
Top view
(3) Seeding C2C12 myoblasts onto 
the GelMA microstructures 
~
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Fig. 1 Schematic of the
experimental procedure to
fabricate the contactless
electrical stimulator for
engineering of functional
muscle tissue
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DMEM at a density of 1.5×106 cells/mL. Then, 100 μL of
this suspension was pipetted onto the GelMA micropattern
and incubated at 37 °C for 30 min to allow for cell seeding
inside the micropattern grooves. Cells loaded within the
GelMA micropattern were then cultured after adding suffi-
cient culture medium. The procedure described here is
shown schematically in Fig. 1. After 2 days of culture, the
culture medium was replaced with the differentiation medi-
um, which was DMEM with 2 % horse serum, 1 nM insulin,
and 1 % P/S. During the culture period, the differentiation
medium was replenished every 48 h.
2.5 Immunostaining of engineered muscle tissue
C2C12 muscle cells were fixed with 3–4 % paraformalde-
hyde for 12 min, followed by a wash with PBS. The cells
were treated with 0.3 % Triton X-100 for 5 min at ambient
temperature to make them permeable. Then the cells were
exposed to 5 % bovine serum albumin dissolved in PBS for
15min. A primarymouse monoclonal IgG antibody (ab-7784,
Abcam®, Japan) to detect fast skeletal myosin was added to
the underlying sample at a dilution of 1:1000 in PBS and
incubated at 4 °C for 24 h. The sample was then washed 3
times with PBS and treated with secondary goat anti-mouse
AlexaFluor® 488 antibody (Invitrogen, USA) at a dilution of
1:1000 in PBS and incubated at 37 °C for 1 h. To visualize α-
actinin, the samples were incubated with monoclonal anti-α-
actinin antibody (Sigma-Aldrich, USA) at a dilution of 1:1000
in PBS for 1 h at ambient temperature and then treated with
Alexa-Fluor 594-conjugated donkey anti-mouse IgG (Invitro-
gen, USA) for 1 h. The samples were stained with 4,6-diami-
dino-2-phenylindole (DAPI) (Vector Laboratories Inc., USA)
(5 mg/mL in PBS), in order to reveal cell nuclei. The pictures
of stained samples were recorded with a fluorescence micro-
scope (Carl Zeiss Observer Z.1, Germany).
2.6 Electrical stimulation of the engineered muscle tissue
On day 8 of culture, the engineered muscle tissue was electri-
cally stimulated through the IDA-Pt electrodes as depicted in
Fig. 1. As the control system, the muscle tissue was kept
without applying the electrical field. For the ES of muscle
tissue, the differentiation medium was replaced with the stim-
ulation medium that was composed of DMEMwith 2 % horse
serum, 1 nM insulin, 2 % MEM essential amino acid, 1 %
MEM nonessential amino acid, and 1 % P/S (Kaji et al. 2010).
Electrical pulses were applied to the muscle tissue using a
waveform generator (WF 1946B Multifunction Synthesizer,
NF Co., Japan) under an ES regime (voltage 10 V, frequency
1 Hz, and duration 10 ms) for 2 days. An oscilloscope (wave
surfer 424; LeCroy Co., Japan) was used to confirm the
generated electric current. During ES of the muscle tissue,
the stimulation medium was replenished every day.
2.7 RNA extraction and cDNA synthesis
Total RNA was extracted from 3 mg of the muscle tissue.
The weighed tissue was placed in liquid nitrogen and thor-
oughly ground with a mortar and pestle. RNAwas extracted
using β-mercaptoethanol and purified according to the man-
ufacturer’s protocol (RNeasy©microkit, Qiagen, Venlo,
Netherlands). Reverse transcription was performed according
to the manufacturer’s instructions (Quantitech Reverse Tran-
scription, Qiagen, Venlo, Netherlands) for up to 3 μg of total
RNA. The temperature profile of the cDNA synthesis protocol
was as follows: 12 μl of sample (3 μg of total RNA) was
diluted with 14 μl of RNase-free water and 4 μl of gDNA
wipeout buffer and incubated for 2 min at 42 °C and then
cooled down to 4 °C. Quantiscript Reverse Transcriptase and
Reverse Transcriptase primer mix were subsequently added,
and the mixture was incubated for 15 min at 42 °C followed
by incubation for 3 min at 95 °C. The samples were kept at
4 °C until use for the quantitative PCR (qPCR).
2.8 Real time PCR
Primer sets for GAPDH, MyoD, myogenin, MRF4, Myf-5,
Mef2c, MLP, sarcomeric actin, α-actinin, MHC-pn, MHC-
IId/x, MHC-IIa, and MHC-IIb were obtained from Operon
Biotechnologies (Tokyo, Japan) and validated for qPCR.
The primer sequences are listed in the Supplementary infor-
mation, Table S1. Real time PCR was performed on a Roche
Lightcycler 1.5 (Roche, Mannheim, Germany) using 2 μl of
cDNA, 2 μl of the primer set (50 μm), and 14 μl of
Lightcycler FastStart DNA Master SYBR Green 1 (Roche,
Mannheim, Germany). Following an initial denaturation step
at 95 °C for 10 min, real time PCR was performed over
45 cycles of 95 °C for 10 s, 62 °C for 10 s, and 72 °C for
20 s, followed by a melt curve analysis. The expression of the
target gene was assessed using the comparative method
(Berdat et al. 2008), and the results were normalized to the
mouse GAPDH gene as the internal reference.
2.9 Statistical analysis
Statistically significant differences were revealed by the
independent Student’s t test for 2 groups of data using the
MINITAB 16.0 statistical software package (Minitab Inc.,
USA). All data are represented as average ± standard devi-
ation, and p-values less than 0.05 were deemed to be statis-
tically significant.
3 Results and discussion
The IDA-Pt electrodes as the electrical stimulator (control
device) and our designed contactless electrical stimulator
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were compared in terms of pH differences, bubble forma-
tion, and appearance due to applied electric field. Figure 2
shows such comparison between two devices. We applied
an AC electrical field (voltage 10 V, frequency 1 Hz, and
duration 10 ms) through devices in the culture medium (i.e.,
DMEM supplemented with 10 % FBS and 1 % P/S) and
evaluated pH changes (as measured by pH meter F-52,
Horiba, Japan), bubble formation, and appearance of devi-
ces. As can be seen, direct contact between the IDA-Pt
electrodes and medium led to noticeable pH changes in
culture medium during the stimulation time (Fig. 2-(a)).
There was a sharp increase in pH within the control medium
during 2 h of stimulation (from pH 7.45 for initial pH buffer
to pH 7.69 for the same buffer after 2 h of stimulation);
however, it almost remained unchanged until the end of
stimulation probably due to the formation of passivation
layer on the Pt electrodes. In contrast, pH changes within
the medium for the contactless electrical stimulator device
during the stimulation time were negligible. In addition, we
observed bubble formation within the control device during
the stimulation time (Fig. 2-(b)) whereas this phenomenon
was not observed within the contactless electrical stimulator
(Fig. 2-(c)). This gas evolution was also observed in our
previous work where Pt microelectrodes were employed to
stimulate cardiac myocytes (Nishizawa et al. 2008). Finally,
it seems that the ES through control device for 24 h caused
Pt corrosion and damage to the device (Fig. 2-(d)); however,
Pt electrodes remained fully intact within the contactless
electrical stimulator (Fig. 2-(e)). The latter finding is in
accordance with previous studies in which Pt corrosion as
a result of long-time ES was studied using mass spectrom-
etry (Hibbert et al. 2000) and reciprocal derivative chrono-
potentiometry (Musa et al. 2011) and it was shown that Pt
underwent corrosion during the ES causing to release trace
quantities of byproducts that could be toxic to tissues. To
solve this problem, Nagamine et al. (Nagamine et al. 2011)
used Pt microelectrodes coated with poly(3,4-ethylenediox-
ythiophene) as a conductive material for the ES of muscle
tissue. This chemical modification of Pt electrodes led to the
chemical stability of electrodes within the ES period. Note
that they did not directly culture the muscle cells on the Pt
microelectrodes and therefore as shown by authors, the
electric field was dramatically decreased inversely propor-
tional to the distance from the electrodes. In contrast, our
designed electrical stimulator enabled close placement of
electrodes with the muscle tissue through a thin coverslip
leading to an efficient and homogeneous electric field within
the muscle tissue.
Most C2C12 myoblast cells that were loaded onto the
GelMA micropattern oriented and elongated along the
ridge-groove direction. This phenomenon is referred to as
contact guidance, in which most cells tend to orient and
elongate along grooves or fiber axes (Riboldi et al. 2005). A
high degree of C2C12 myoblast alignment is needed to
obtain highly aligned myotubes (as a fundamental require-
ment for functional muscle tissues) because the myoblasts
fuse together to form myotubes in an end-to-end configura-
tion (Clark et al. 2002). Myotube alignment is crucial to
maximize the contractility of muscle tissue (Bian et al.
2011). Figure 3 demonstrates the myotube alignment ob-
served after 10 days of culture (i.e., after the ES). It also
shows high expression levels of myosin heavy chain and α-
actinin within multinucleated myotubes in the muscle tissue
due to an efficient ES through contactless electrical stimu-
lator. Expression levels of target genes (i.e., MyoD, Myf-5,
myogenin, MRF4, Mef2c, MLP, sarcomeric actin, α-actinin,
perinatal myosin heavy chain (MHC-pn), MHC-IId/x,
MHC-IIa, and MHC-IIb) were also evaluated after applying
the ES using the designed contactless electrical stimulator
on day 10 of culture. The cultures that were electrically
stimulated were compared to the corresponding samples
without ES (control samples) (Fig. 4). As shown, except
myogenin and MRF4, the expression levels of all underly-
ing genes significantly increased upon the ES application.
Indeed, MRF4 and myogenin interact with muscle LIM
Bubbles 
(b)
(a)
(d) (e)
(c)
Fig. 2 Comparison between interdigitated array of Pt electrodes as the
electrical stimulator (control) and corresponding secured device with
glass coverslip (contactless electrical stimulator). (a) pH changes ver-
sus the stimulation time for both control and contactless electrical
stimulator devices. Evaluation of bubble formation during the electrical
stimulation within control (b) and contactless electrical stimulator
devices (c). Appearance of control (d) and contactless electrical stim-
ulator devices (e) after electrical stimulation (voltage 10 V, frequency
1 Hz, and duration 10 ms) for 24 h. Scale bar shows 100 μm (*p<0.05)
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protein during muscle maturation and are highly expressed
in mature adult skeletal muscle (Arber et al. 1994). Contrac-
tion of myotubes due to ES is associated with sarcomere
development. As an electric field is applied, the sarcomere
assembly is increased due to the manipulation of the intra-
cellular Ca2+ transient through the depolarization of the cell
membrane potential (Nagamine et al. 2010). Note that ES
promoted the contraction of myotubes as indicated in the
Supplementary information, Movie S1. In contrast, no such
phenomenon was observed for the myotubes without apply-
ing the ES. The expression levels of all underlying target
genes for sarcomere protein development (i.e., sarcomeric
actin, α-actinin, perinatal myosin heavy chain (MHC-pn),
MHC-IId/x, MHC-IIa, and MHC-IIb) were increased upon
applying the electrical field that is in agreement with the
contractile activity of our fabricated muscle tissue. An engi-
neered muscle tissue may provide a good model to investigate
a wide variety of biological phenomena in vitro. However,
there is still a demand to develop a cellular model of muscle
tissues having contractile ability (Kaji et al. 2010). Various
effects of muscle tissue contraction on muscle cells such as
immune responses, metabolic changes, even angiogenesis can
only be evaluated on a muscle tissue model having contractile
ability (Nedachi et al. 2008). Therefore, such cellular system
is of great interest. Taken together, this work introduced a
contactless electrical stimulator that was effective for the ES
of muscle tissue.
Applying efficient electric field through thin isolated
barriers (e.g., PDMS layer or glass coverslip) has already
been developed and employed for a wide range of cell
manipulation applications using the dielectrophoresis tech-
nique (Park et al. 2009; Shafiee et al. 2009; Shafiee et al.
2010); however, here, we reported the first application of
this system for the ES of an engineered tissue. Eventually, a
major hurdle to widespread clinical applications of engi-
neered muscle tissues is cost and time to fabricate an engi-
neered product (Adam 2012). Using the suggested electrical
stimulator, it is feasible to employ cheap, disposable, and
low stable electrodes because we do not need to worry about
the corrosion problem of electrode materials in high corro-
sive physiological mediums. Therefore, the contactless elec-
trical stimulator may decrease the final cost of an engineered
tissue. Due to the wide array of potential applications of ES
to two- and three-dimensional (2D and 3D) cell and tissue
constructs (Hronik-Tupaj and Kaplan 2012), the proposed
device could be of great interest for a variety of biological
applications as a tool to create noninvasive, accurate, safe,
and highly reproducible direct and alternative electric fields.
Microgrooved GelMA direction
(a) (b) (c)
Fig. 3 Phase contrast (a) and corresponding immunofluorescence images of myosin heavy chains (green)-cell nuclei (blue) (b) and α-actinin (red)-
cell nuclei (blue) (c) for myotubes cultured on the microgrooved GelMA hydrogel on day 10 of culture. Scale bar shows 100 μm
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Expression levels were normal-
ized with respect to the internal
reference gene GAPDH
(*p<0.05)
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4 Conclusions
Here, we proposed a contactless electrode to electrically
stimulate engineered muscle tissue, which minimizes hydro-
lysis of the culture medium, joule heating of the medium,
contamination of the culture medium due to products of
electrodes corrosion, and surface fouling of electrodes. The
efficient stimulation of skeletal muscle tissues using this
platform was also shown in terms of contractile activity
and higher maturation compared to muscle tissues without
applying the electrical field.
Acknowledgments S.A. conceived the idea. S.A. and J.R. designed
the research. S.A., J.R., H.K., H.S., A.K., and T.M. analyzed the results.
S.A. wrote the paper. G.C-U. synthesized the GelMA hydrogel. S.A. and
J.R. performed all other experiments. H.K., H.S., A.K., and T.M. super-
vised the research. All authors read the manuscript, commented on it, and
approved its content. This work was supported by the World Premier
International Research Center Initiative (WPI), MEXT, Japan.
References
C. Adam, Endogenous musculoskeletal tissue engineering - a focused
perspective. Cell Tissue Res. 347, 489–499 (2012)
S. Ahadian, J. Ramón-Azcón, S. Ostrovidov, G. Camci-Unal, V.
Hosseini, H. Kaji, K. Ino, H. Shiku, A. Khademhosseini, T.
Matsue, Interdigitated array of Pt electrodes as a new platform for
the electrical stimulation of engineered muscle tissue. Lab Chip. 12,
3494–3503 (2012)
S. Arber, G. Halder, P. Caroni, Muscle LIM protein, a novel essential
regulator of myogenesis, promotes myogenic differentiation. Cell
79, 221–231 (1994)
H. Aubin, J.W. Nichol, C.B. Hutson, H. Bae, A.L. Sieminski, D.M.
Cropek, P. Akhyari, A. Khademhosseini, Directed 3D cell align-
ment and elongation in microengineered hydrogels. Biomaterials
31, 6941–6951 (2010)
D. Berdat, A.C. Martin Rodriguez, F. Herrera, M.A.M. Gijs, Label-free
detection of DNAwith interdigitated micro-electrodes in a fluidic
cell. Lab Chip 8, 302–308 (2008)
W. Bian, M. Juhas, T.W. Pfeiler, N. Bursac, Local tissue geometry
determines contractile force generation of engineered muscle net-
works. Tissue Eng. Part A. 18, 957–967 (2011)
P. Clark, G.A. Dunn, A. Knibbs, M. Peckham, Alignment of myoblasts
on ultrafine gratings inhibits fusion in vitro. Int. J. Biochem. Cell
Biol. 34, 816–825 (2002)
H. Fujita, T. Van Dau, K. Shimizu, R. Hatsuda, S. Sugiyama, E.
Nagamori, Designing of a Si-MEMS device with an integrated
skeletal muscle cell-based bio-actuator. Biomed. Microdevices
13, 123–129 (2011)
A.M. Ghaemmaghami, M.J. Hancock, H. Harrington, H. Kaji, A.
Khademhosseini, Biomimetic tissues on a chip for drug discovery.
Drug Discov. Today 17, 173–181 (2012)
D.B. Hibbert, K. Weitzner, B. Tabor, P. Carter, Mass changes and
dissolution of platinum during electrical stimulation in artificial
perilymph solution. Biomaterials 21, 2177–2182 (2000)
S. Hinds, W. Bian, R.G. Dennis, N. Bursac, The role of extracellular
matrix composition in structure and function of bioengineered
skeletal muscle. Biomaterials 32, 3575–3583 (2011)
V. Hosseini, S. Ahadian, S. Ostrovidov, G. Camci-Unal, S. Chen, H.
Kaji, M. Ramalingam, A. Khademhosseini, Engineered
contractile skeletal muscle tissue on a microgrooved methacry-
lated gelatin substrate. Tissue Eng. Part A. (2012)
M. Hronik-Tupaj, D.L. Kaplan, A review of the responses of two- and
three-dimensional engineered tissues to electric fields. Tissue
Eng. Part B: Rev. 18, 167–180 (2012)
H. Kaji, T. Ishibashi, K. Nagamine, M. Kanzaki, M. Nishizawa, Elec-
trically induced contraction of C2C12 myotubes cultured on a
porous membrane-based substrate with muscle tissue-like stiff-
ness. Biomaterials 31, 6981–6986 (2010)
A. Khademhosseini, R. Langer, J. Borenstein, J.P. Vacanti, Microscale
technologies for tissue engineering and biology. Proc. Natl. Acad.
Sci. U. S. A. 103, 2480–2487 (2006)
M. Koning, M.C. Harmsen, M.J.A. van Luyn, P.M.N. Werker, Current
opportunities and challenges in skeletal muscle tissue engineer-
ing. J. Tissue Eng. Regen. Med. 3, 407–415 (2009)
S. Musa, D.R. Rand, C. Bartic, W. Eberle, B. Nuttin, G. Borghs,
Coulometric detection of irreversible electrochemical reactions
occurring at Pt microelectrodes used for neural stimulation. Anal.
Chem. 83, 4012–4022 (2011)
K. Nagamine, T. Kawashima, T. Ishibashi, H. Kaji, M. Kanzaki, M.
Nishizawa, Micropatterning contractile C2C12 myotubes em-
bedded in a fibrin gel. Biotechnol. Bioengin. 105, 1161–1167
(2010)
K. Nagamine, T. Kawashima, S. Sekine, Y. Ido, M. Kanzaki, M.
Nishizawa, Spatiotemporally controlled contraction of micropat-
terned skeletal muscle cells on a hydrogel sheet. Lab Chip 11,
513–517 (2011)
T. Nedachi, H. Fujita, M. Kanzaki, Contractile C2C12 myotube model
for studying exercise-inducible responses in skeletal muscle. Am.
J. Physiol.-Endocrinol. Metab. 295, E1191–E1204 (2008)
M. Nishizawa, H. Nozaki, H. Kaji, T. Kitazume, N. Kobayashi, T.
Ishibashi, T. Abe, Electrodeposition of anchored polypyrrole film
on microelectrodes and stimulation of cultured cardiac myocytes.
Biomaterials 28, 1480–1485 (2008)
H. Park, R. Bhalla, R. Saigal, Effects of electrical stimulation in
C2C12 muscle constructs. J. Tissue Eng. Regen. Med. 2, 279–287
(2008)
K. Park, H.-J. Suk, D. Akin, R. Bashir, Dielectrophoresis-based cell
manipulation using electrodes on a reusable printed circuit board.
Lab Chip 9, 2224–2229 (2009)
N.A. Peppas, J.Z. Hilt, A. Khademhosseini, R. Langer, Hydrogels in
biology and medicine: from molecular principles to bionanotech-
nology. Adv. Mater. 18, 1345–1360 (2006)
J. Ramón-Azcón, S. Ahadian, R. Obregon, G. Camci-Unal, S. Ostrovidov,
V. Hosseini, H. Kaji, K. Ino, H. Shiku, A. Khademhosseini, T.
Matsue, Gelatin methacrylate as a promising hydrogel for
3D microscale organization and proliferation of dielectrophor-
etically patterned cells. Lab Chip 12, 2959–2969 (2012)
S.A. Riboldi, M. Sampaolesi, P. Neuenschwander, G. Cossu, S. Mantero,
Electrospun degradable polyesterurethane membranes: potential
scaffolds for skeletal muscle tissue engineering. Biomaterials 26,
4606–4615 (2005)
C.A. Rossi, M. Pozzobon, P. De Coppi, Advances in musculoskeletal
tissue engineering: moving towards therapy. Organogenesis 6,
167–172 (2010)
H. Shafiee, J. Caldwell, M. Sano, R. Davalos, Contactless dielectro-
phoresis: a new technique for cell manipulation. Biomed. Micro-
devices 11, 997–1006 (2009)
H. Shafiee, M.B. Sano, E.A. Henslee, J.L. Caldwell, R.V. Davalos,
Selective isolation of live/dead cells using contactless dielectro-
phoresis (cDEP). Lab Chip 10, 438–445 (2010)
B.V. Slaughter, S.S. Khurshid, O.Z. Fisher, A. Khademhosseini, N.A.
Peppas, Hydrogels in regenerative medicine. Adv. Mater. 21,
3307–3329 (2009)
H. Vandenburgh, High-content drug screening with engineered mus-
culoskeletal tissues. Tissue Eng. Part B: Rev. 16, 55–64 (2009)
Biomed Microdevices (2013) 15:109–115 115
